James A. Johnson

1.0k total citations
18 papers, 774 citations indexed

About

James A. Johnson is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, James A. Johnson has authored 18 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in James A. Johnson's work include Catalytic C–H Functionalization Methods (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Cancer Treatment and Pharmacology (3 papers). James A. Johnson is often cited by papers focused on Catalytic C–H Functionalization Methods (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Cancer Treatment and Pharmacology (3 papers). James A. Johnson collaborates with scholars based in United States and India. James A. Johnson's co-authors include Dalibor Sameš, B.D. Dangel, Ning Li, Soong‐Hoon Kim, Craig R. Fairchild, Byron H. Long, Gregory D. Vite, Francis Y. F. Lee, Xiaoping Zheng and R. M. Borzilleri and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

James A. Johnson

16 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Johnson United States 10 639 135 119 102 83 18 774
Jason Xiang United States 18 621 1.0× 78 0.6× 171 1.4× 46 0.5× 60 0.7× 23 916
Jung‐Nyoung Heo South Korea 18 653 1.0× 61 0.5× 256 2.2× 50 0.5× 40 0.5× 41 874
Nicholas J. Newcombe United Kingdom 16 500 0.8× 88 0.7× 304 2.6× 33 0.3× 57 0.7× 25 751
Sajiv K. Nair United States 14 388 0.6× 90 0.7× 202 1.7× 37 0.4× 23 0.3× 26 619
Michaël Prakesch Canada 15 324 0.5× 64 0.5× 287 2.4× 56 0.5× 17 0.2× 25 609
Manus Ipek United States 12 252 0.4× 80 0.6× 143 1.2× 25 0.2× 48 0.6× 14 511
Daniel Kuzmich United States 12 287 0.4× 93 0.7× 111 0.9× 35 0.3× 74 0.9× 23 527
G. R. KIECZYKOWSKI United States 14 441 0.7× 116 0.9× 163 1.4× 65 0.6× 29 0.3× 19 667
Joydeep Kant United States 16 521 0.8× 166 1.2× 201 1.7× 52 0.5× 16 0.2× 41 658
Nicole C. Goodwin United States 10 505 0.8× 44 0.3× 260 2.2× 91 0.9× 14 0.2× 13 893

Countries citing papers authored by James A. Johnson

Since Specialization
Citations

This map shows the geographic impact of James A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Johnson more than expected).

Fields of papers citing papers by James A. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Johnson. The network helps show where James A. Johnson may publish in the future.

Co-authorship network of co-authors of James A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Johnson. A scholar is included among the top collaborators of James A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Johnson. James A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Johnson, James A., et al.. (2025). First North American Record of a Kentish Plover (Anarhynchus alexandrinus). 56(1). 51–56.
2.
Johnson, James A., et al.. (2022). Commensal Urinary Lactobacilli Inhibit Major Uropathogens In Vitro With Heterogeneity at Species and Strain Level. Frontiers in Cellular and Infection Microbiology. 12. 870603–870603. 22 indexed citations
3.
Wurtz, Nicholas R., James A. Johnson, Andrew Q. Viet, et al.. (2022). Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists. ACS Medicinal Chemistry Letters. 13(6). 943–948. 4 indexed citations
4.
Johnson, James A., Soong‐Hoon Kim, Jiang Ji, et al.. (2021). Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. Journal of Medicinal Chemistry. 64(6). 3086–3099. 14 indexed citations
5.
Pi, Zulan, James A. Johnson, Wei Meng, et al.. (2021). Identification of 6-Hydroxypyrimidin-4(1H)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists. ACS Medicinal Chemistry Letters. 12(11). 1766–1772. 6 indexed citations
6.
Finlay, Heather J., James A. Johnson, John Lloyd, et al.. (2016). Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a PotentIKurInhibitor. ACS Medicinal Chemistry Letters. 7(9). 831–834. 11 indexed citations
7.
Jiang, Ji, Heather J. Finlay, James A. Johnson, et al.. (2016). Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(14). 3278–3281. 1 indexed citations
8.
Zhang, Xiaojun, Peter W. Glunz, James A. Johnson, et al.. (2016). Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex. Journal of Medicinal Chemistry. 59(15). 7125–7137. 16 indexed citations
9.
Lloyd, John, Heather J. Finlay, James A. Johnson, et al.. (2015). Pseudosaccharin amines as potent and selective KV1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 25(21). 4983–4986. 5 indexed citations
10.
Johnson, James A., Ningning Xu, Yoon Jeon, et al.. (2014). Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(14). 3018–3022. 5 indexed citations
11.
Johnson, James A., Ning Li, & Dalibor Sameš. (2002). Total Synthesis of (−)-Rhazinilam:  Asymmetric C−H Bond Activation via the Use of a Chiral Auxiliary. Journal of the American Chemical Society. 124(24). 6900–6903. 151 indexed citations
12.
Regueiro‐Ren, Alicia, R. M. Borzilleri, Xiaoping Zheng, et al.. (2001). Synthesis and Biological Activity of Novel Epothilone Aziridines. Organic Letters. 3(17). 2693–2696. 62 indexed citations
13.
Dangel, B.D., James A. Johnson, & Dalibor Sameš. (2001). Selective Functionalization of Amino Acids in Water: A Synthetic Method via Catalytic C−H Bond Activation. Journal of the American Chemical Society. 123(33). 8149–8150. 189 indexed citations
14.
Borzilleri, R. M., Xiaoping Zheng, Robert J. Schmidt, et al.. (2000). A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products. Journal of the American Chemical Society. 122(37). 8890–8897. 104 indexed citations
15.
Johnson, James A. & Dalibor Sameš. (2000). C−H Bond Activation of Hydrocarbon Segments in Complex Organic Molecules:  Total Synthesis of the Antimitotic Rhazinilam. Journal of the American Chemical Society. 122(26). 6321–6322. 122 indexed citations
16.
Johnson, James A., Soong‐Hoon Kim, Marc Bifano, et al.. (2000). Synthesis, Structure Proof, and Biological Activity of Epothilone Cyclopropanes. Organic Letters. 2(11). 1537–1540. 60 indexed citations
17.
Johnson, James A.. (1999). Interview with Brigadier General Donna F. Barbisch, D.H.A., Senior Advisor to the Biological Warfare Improved Response Program. Journal of Healthcare Management. 44(5). 329–338. 1 indexed citations
18.
Johnson, James A., et al.. (1976). Sales Tax Reform: A Critique of the Federal Government's Proposals. Canadian Public Policy. 2(4). 638–638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Xiang Breakdown of academic impact, for papers by Jung‐Nyoung Heo Breakdown of academic impact, for papers by Nicholas J. Newcombe Breakdown of academic impact, for papers by Sajiv K. Nair Breakdown of academic impact, for papers by Michaël Prakesch Breakdown of academic impact, for papers by Manus Ipek Breakdown of academic impact, for papers by Daniel Kuzmich Breakdown of academic impact, for papers by G. R. KIECZYKOWSKI Breakdown of academic impact, for papers by Joydeep Kant Breakdown of academic impact, for papers by Nicole C. Goodwin
Rankless by CCL
2026